BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 36304051)

  • 21. Brief Report: Impact of PrEP Training for Family Planning Providers on HIV Prevention Counseling and Patient Interest in PrEP in Atlanta, Georgia.
    Sales JM; Cwiak C; Haddad LB; Phillips A; Powell L; Tamler I; Sheth AN
    J Acquir Immune Defic Syndr; 2019 Aug; 81(4):414-418. PubMed ID: 30985558
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Integrating Pre-Exposure Prophylaxis Delivery in Public Health Family Planning Clinics: Lessons Learned From a Programmatic Implementation Project in Kenya.
    Mugwanya KK; Kinuthia J
    Front Reprod Health; 2021; 3():683415. PubMed ID: 36304007
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Integration of family planning services with HIV treatment for women of reproductive age attending ART clinic in Oromia regional state, Ethiopia.
    Demissie DB; Mmusi-Phetoe R
    Reprod Health; 2021 May; 18(1):102. PubMed ID: 34022885
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A community-based mobile clinic model delivering PrEP for HIV prevention to adolescent girls and young women in Cape Town, South Africa.
    Rousseau E; Bekker LG; Julies RF; Celum C; Morton J; Johnson R; Baeten JM; O'Malley G
    BMC Health Serv Res; 2021 Aug; 21(1):888. PubMed ID: 34454505
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Impact of HIV Pre-Exposure Prophylaxis (PrEP) Counseling on PrEP Knowledge and Attitudes Among Women Seeking Family Planning Care.
    O'Connell HR; Criniti SM
    J Womens Health (Larchmt); 2021 Jan; 30(1):121-130. PubMed ID: 32493156
    [No Abstract]   [Full Text] [Related]  

  • 26. Sexual health needs of female sex workers in Côte d'Ivoire: a mixed-methods study to prepare the future implementation of pre-exposure prophylaxis (PrEP) for HIV prevention.
    Becquet V; Nouaman M; Plazy M; Masumbuko JM; Anoma C; Kouame S; Danel C; Eholie SP; Larmarange J;
    BMJ Open; 2020 Jan; 10(1):e028508. PubMed ID: 31919122
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incorporating oral PrEP into standard prevention services for South African women: a nested interrupted time-series study.
    Donnell D; Beesham I; Welch JD; Heffron R; Pleaner M; Kidoguchi L; Palanee-Phillips T; Ahmed K; Baron D; Bukusi EA; Louw C; Mastro TD; Smit J; Batting JR; Malahleha M; Bailey VC; Beksinska M; Rees H; Baeten JM;
    Lancet HIV; 2021 Aug; 8(8):e495-e501. PubMed ID: 34126052
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An Evaluation of an Enhanced Model of Integrating Family Planning Into HIV Treatment Services in Zambia, April 2018-June 2019.
    Medley A; Tsiouris F; Pals S; Senyana B; Hanene S; Kayeye S; Casquete RR; Lasry A; Braaten M; Aholou T; Kasonde P; Chisenga T; Mweebo K; Harris TG
    J Acquir Immune Defic Syndr; 2023 Feb; 92(2):134-143. PubMed ID: 36240748
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Integrating HIV Pre-Exposure Prophylaxis into Family Planning Care: A RE-AIM Framework Evaluation.
    Brant AR; Dhillon P; Hull S; Coleman M; Ye PP; Lotke PS; Folan J; Scott RK
    AIDS Patient Care STDS; 2020 Jun; 34(6):259-266. PubMed ID: 32484743
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomized evaluation and cost-effectiveness of HIV and sexual and reproductive health service referral and linkage models in Zambia.
    Hewett PC; Nalubamba M; Bozzani F; Digitale J; Vu L; Yam E; Nambao M
    BMC Public Health; 2016 Aug; 16():785. PubMed ID: 27519185
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fertility intentions and long-acting reversible contraceptive use among HIV-negative single mothers in Zambia.
    Li JL; Kilembe W; Inambao M; Vwalika B; Parker R; Sharkey T; Visoiu AM; Haddad LB; Wall KM; Allen S
    Am J Obstet Gynecol; 2020 Apr; 222(4S):S917.e1-S917.e15. PubMed ID: 31953114
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pre-Exposure Prophylaxis for HIV Prevention in Women: Current Status and Future Directions.
    Hodges-Mameletzis I; Fonner VA; Dalal S; Mugo N; Msimanga-Radebe B; Baggaley R
    Drugs; 2019 Aug; 79(12):1263-1276. PubMed ID: 31309457
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prospective study of oral pre-exposure prophylaxis initiation and adherence among young women in KwaZulu-Natal, South Africa.
    Mansoor LE; Lewis L; Naicker CL; Harkoo I; Dawood H; Naidoo K; Gengiah TN; Samsunder N; Beesham I; Abdool Karim SS; Abdool Karim Q
    J Int AIDS Soc; 2022 Jul; 25(7):e25957. PubMed ID: 35785472
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rethinking HIV prevention to prepare for oral PrEP implementation for young African women.
    Celum CL; Delany-Moretlwe S; McConnell M; van Rooyen H; Bekker LG; Kurth A; Bukusi E; Desmond C; Morton J; Baeten JM
    J Int AIDS Soc; 2015; 18(4 Suppl 3):20227. PubMed ID: 26198350
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Landscape Analysis of Offering HIV Testing Services Within Family Planning Service Delivery.
    Drake AL; Quinn C; Kidula N; Sibanda E; Steyn P; Barr-DiChiara M; Jamil MS; Rodolph M; Gaffield ME; Kiarie J; Baggaley R; Johnson C
    Front Reprod Health; 2021; 3():657728. PubMed ID: 36304029
    [No Abstract]   [Full Text] [Related]  

  • 36. The PrEPARE Pretoria Project: protocol for a cluster-randomized factorial-design trial to prevent HIV with PrEP among adolescent girls and young women in Tshwane, South Africa.
    Wechsberg WM; Browne FA; Ndirangu J; Bonner CP; Minnis AM; Nyblade L; Speizer IS; Howard BN; Myers B; Ahmed K
    BMC Public Health; 2020 Sep; 20(1):1403. PubMed ID: 32933510
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contraceptive use among HIV-infected women and men receiving antiretroviral therapy in Lusaka, Zambia: a cross-sectional survey.
    Hancock NL; Chibwesha CJ; Bosomprah S; Newman J; Mubiana-Mbewe M; Sitali ES; Bolton-Moore C; Mbwili-Muleya C; Chi BH
    BMC Public Health; 2016 May; 16():392. PubMed ID: 27175483
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Models of HIV Pre-Exposure Prophylaxis Care Used in Title X Family Planning Clinics in the Southern U.S.
    Piper KN; Escoffery C; Sales JM; Sheth AN
    J Adolesc Health; 2021 Mar; 68(3):480-487. PubMed ID: 33160826
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estimating HIV pre-exposure prophylaxis need and impact in Malawi, Mozambique and Zambia: A geospatial and risk-based analysis.
    Stelzle D; Godfrey-Faussett P; Jia C; Amiesimaka O; Mahy M; Castor D; Hodges-Mameletzis I; Chitembo L; Baggaley R; Dalal S
    PLoS Med; 2021 Jan; 18(1):e1003482. PubMed ID: 33428611
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modelling impact and cost-effectiveness of oral pre-exposure prophylaxis in 13 low-resource countries.
    Pretorius C; Schnure M; Dent J; Glaubius R; Mahiane G; Hamilton M; Reidy M; Matse S; Njeuhmeli E; Castor D; Kripke K
    J Int AIDS Soc; 2020 Feb; 23(2):e25451. PubMed ID: 32112512
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.